Elkem (ELK) SEB Nordic Seminar presentation summary
Event summary combining transcript, slides, and related documents.
SEB Nordic Seminar presentation summary
14 Jan, 2026Company overview and strategy
Operates globally with ~7,200 employees and NOK ~33 billion in 2024 revenues.
Structured into three divisions: Silicones, Silicon Products, and Carbon Solutions, each with global leadership.
Initiated a strategic review to sell the Silicones division, aiming to focus on Silicon Products and Carbon Solutions.
Over 120 years of industrial history rooted in Norwegian expertise and renewable energy use.
Strong cost position due to operational excellence, upstream integration, and long-term renewable energy agreements.
Market environment and performance
EU and US trade barriers impact silicon and ferrosilicon markets, with new duties and quotas affecting pricing.
Ferrosilicon prices in the EU rose ~25% after safeguard measures, while silicon prices remain low due to weak demand.
Silicones market in China saw a 23% price increase in Q4 2025 due to production cuts, but demand remains weak.
Increased infrastructure and defense spending in Europe and NATO expected to boost demand for silicon and ferroalloys.
Silicon is critical for strategic industries including electronics, healthcare, construction, and defense.
Financial highlights and investment case
Q3 results supported by operational performance and cost improvements despite low sales prices.
Operating income CAGR of 8% and EBITDA margin of 17% (2020–2024), exceeding targets; ex-Silicones, CAGR is 11% and EBITDA margin 23%.
Carbon Solutions delivered strong margins; Silicones stable due to improved cost and market positions.
Strategic review and exclusive sales process for Silicones division progressing, with expected closing in H1 2026.
Positioned as a global leader in advanced silicon-based materials, with a resilient, geographically diverse business model and strong ESG focus.
Latest events from Elkem
- All agenda items, including the Bluestar share deal and capital decrease, were approved.ELK
EGM 20269 Mar 2026 - Silicones division sale to Bluestar and weak Q4 2025 results mark a major transformation.ELK
Q4 202513 Feb 2026 - EBITDA stable at NOK 1,030m; net profit up on tax assets, Silicones improved despite weak demand.ELK
Q2 20243 Feb 2026 - EBITDA hit NOK 1,235 million, up 131% year-over-year, driven by Silicones and cost programs.ELK
Q3 202418 Jan 2026 - Strong financial performance and strategic investments drive sustainable growth.ELK
SEB Nordic Seminar presentation14 Jan 2026 - 2024 saw strong financials, strategic portfolio review, and top-tier ESG achievements.ELK
DNB Small & Medium Enterprises Conference presentation14 Jan 2026 - Stable results amid weak markets, with Silicones improving and strategic review ongoing.ELK
Lunch presentation14 Jan 2026 - Q4 EBITDA up 84% YoY; Silicones under review and classified as discontinued operations.ELK
Q4 202423 Dec 2025 - EBITDA up 25% to NOK 898m as Silicones review advances amid market uncertainty.ELK
Q1 202528 Nov 2025